Skip to main content

Advertisement

Log in

Acute Inhibition of Rho-Kinase Attenuates Pulmonary Hypertension in Patients with Congenital Heart Disease

  • Case Report
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

This study aimed to determine whether the Rho-kinase–mediated pathway is involved in the pathogenesis of left-to-right shunt–induced pulmonary hypertension and whether fasudil exhibits acute beneficial effects on the hemodynamics of these patients. A total of 12 patients with a mean age of 12.3 years were enrolled in a self-controlled prospective study. All the patients had a diagnosis of congenital heart disease with slight to moderate pulmonary hypertension and were scheduled for transcatheter closure. After placement of the catheters, 30 mg/kg fasudil was injected intravenously over 30 min under room air conditions. Hemodynamic parameters including pulmonary artery systolic pressure (PASP), pulmonary vascular resistance (PVR), systemic artery pressure (SAP), systemic vascular resistance (SVR), cardiac input, and blood oxygen saturation were measured and calculated at baseline and 30 min after fasudil injection. After fasudil treatment, PASP decreased to a level 33.03 ± 6.64% less than baseline value (p < 0.01), and maximal PVR decreased to a level 33.03 ± 6.64% less than baseline value (< 0.01). Cardiac input increased to a level 7.7 ± 5.2% more than baseline value (< 0.05), and mixed venous oxygen saturation significantly increased to a level 7.7 ± 5.2% more than baseline value (p < 0.01). The left-to-right shunt ratio (QP/QS) also tended to increase (16.2 ± 12.5% of baseline value; p < 0.01). Whereas SAP showed only a slight decrease (−1.6 ± 3.1% of baseline value; p = 0.08), SVR significantly decreased (−10.2 ± 12.2% of baseline value; < 0.01), and the PVR/SVR ratio tended to decrease (−23.9 ± 15.1% of baseline value). In conclusion, Rho-kinase is involved in the pathogenesis of left-to-right shunt–induced pulmonary hypertension, and fasudil is a novel therapeutic approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Abe K, Shimokawa H, Morikawa K et al (2004) Long-term treatment with a rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats. Circ Res 94:385–393

    Article  PubMed  CAS  Google Scholar 

  2. Chihara K, Amano M, Nakamura N et al (1997) Cytoskeletal rearrangements and transcriptional activation of c-fos serum response element by rho-kinase. J Biol Chem 272:25121–25127

    Article  PubMed  CAS  Google Scholar 

  3. Civelek M, Ainslie K, Garanich JS et al (2002) Smooth muscle cells contract in response to fluid flow via a Ca2+-independent signaling mechanism. J Appl Physiol 93:1907–1917

    PubMed  CAS  Google Scholar 

  4. Ellerbroek SM, Wennerberg K, Burridge K (2003) Serine phosphorylation negatively regulates RhoA in vivo. J Biol Chem 278:19023–19031

    Article  PubMed  CAS  Google Scholar 

  5. Fagan KA, Oka M, Bauer NR et al (2004) Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of rho-kinase. Am J Physiol Lung Cell Mol Physiol 287:L656–L664

    Article  PubMed  CAS  Google Scholar 

  6. Feng J, Ito M, Ichikawa K et al (1999) Inhibitory phosphorylation site for rho-associated kinase on smooth muscle myosin phosphatase. J Biol Chem 274:37385–37390

    Article  PubMed  CAS  Google Scholar 

  7. Guilluy C, Sauzeau V, Rolli-Derkinderen M et al (2005) Inhibition of RhoA/Rho-kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension. Br J Pharmacol 146:1010–1018

    Article  PubMed  CAS  Google Scholar 

  8. Hall A (1998) Rho GTPases and the actin cytoskeleton. Science 279:509–514

    Article  PubMed  CAS  Google Scholar 

  9. Higashi M, Shimokawa H, Hattori T et al (2003) Long-term inhibition of rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ Res 93:767–775

    Article  PubMed  CAS  Google Scholar 

  10. Ishikura K, Yamada N, Ito M et al (2006) Beneficial acute effects of rho-kinase inhibitor in patients with pulmonary arterial hypertension. Circ J 70:174–178

    Article  PubMed  CAS  Google Scholar 

  11. Katsumi A, Milanini J, Kiosses WB et al (2002) Effects of cell tension on the small GTPase rac. J Cell Biol 158:153–164

    Article  PubMed  CAS  Google Scholar 

  12. Ming XF, Viswambharan H, Barandier C et al (2002) Rho GTPase/Rho-kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol Cell Biol 22:8467–8477

    Article  PubMed  CAS  Google Scholar 

  13. Nagaoka T, Morio Y, Casanova N et al (2004) Rho/Rho-kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol 287:L665–L672

    Article  PubMed  CAS  Google Scholar 

  14. Narumiya S (1996) The small GTPase rho: cellular functions and signal transduction. J Biochem (Tokyo) 120:215–228

    CAS  Google Scholar 

  15. Numaguchi K, Eguchi S, Yamakawa T et al (1999) Mechanotransduction of rat aortic vascular smooth muscle cells requires RhoA and intact actin filaments. Circ Res 85:5–11

    PubMed  CAS  Google Scholar 

  16. Putnam AJ, Cunningham JJ, Pillemer BB et al (2003) External mechanical strain regulates membrane targeting of rho GTPases by controlling microtubule assembly. Am J Physiol Cell Physiol 284:C627–C639

    PubMed  CAS  Google Scholar 

  17. Sauzeau V, Le Jeune H, Cario-Toumaniantz C et al (2000) Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 275:21722–21729

    Article  PubMed  CAS  Google Scholar 

  18. Shimokawa H, Seto M, Katsumata N et al (1999) Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res 43:1029–1039

    Article  PubMed  CAS  Google Scholar 

  19. Somlyo AP, Somlyo AV (2003) Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83:1325–1358

    PubMed  CAS  Google Scholar 

  20. Uehata M, Ishizaki T, Satoh H et al (1997) Calcium sensitization of smooth muscle mediated by a rho-associated protein kinase in hypertension. Nature 389:990–994

    Article  PubMed  CAS  Google Scholar 

  21. Williams B (1998) Mechanical influences on vascular smooth muscle cell function. J Hypertens 16:1921–1929

    Article  PubMed  CAS  Google Scholar 

  22. Wilson E, Mai Q, Sudhir K et al (1993) Mechanical strain induces growth of vascular smooth muscle cells via autocrine action of PDGF. J Cell Biol 123:741–747

    Article  PubMed  CAS  Google Scholar 

  23. Wilson E, Sudhir K, Ives HE (1995) Mechanical strain of rat vascular smooth muscle cells is sensed by specific extracellular matrix/integrin interactions. J Clin Invest 96:2364–2372

    Article  PubMed  CAS  Google Scholar 

  24. Wolfrum S, Dendorfer A, Rikitake Y et al (2004) Inhibition of rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol 24:1842–1847

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We are grateful to Professor Shuping Ge, a doctor at Texas Children’s Hospital, for his linguistic comments and help with the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ruopeng Sun.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, F., Xia, W., Yuan, S. et al. Acute Inhibition of Rho-Kinase Attenuates Pulmonary Hypertension in Patients with Congenital Heart Disease. Pediatr Cardiol 30, 363–366 (2009). https://doi.org/10.1007/s00246-008-9315-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-008-9315-z

Keywords

Navigation